Riskpilot← Back to searchSign inGet full accessOcampo medical AB
ABIn liquidationOrg 5593372005Tertiary education · NACE 8540Est. 20210 employees
Revenue 2025
SEK 0
EBITDA margin
—
-830% vs 2024
Equity ratio
42.3%
Financial strength
Net profit 2025
SEK -9K
-770% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -9K | -830% |
| Net profit | SEK -9K | -770% |
| Total assets | SEK 39K | -4% |
| Equity | SEK 16K | -35% |
| Employees | 0 | — |
Legal name
Ocampo medical AB
Org number
5593372005
Legal form
Aktiebolag
NACE code
8540 · Tertiary education
Founded
27 september 2021
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Konsultverksamhet inom medicin, utbildning och handledning.
Address
Email
lars@forwardekonomi.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 35 | 16 | 10 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | 12 | 1 | −1 | −9 |
| Depreciation & amort. | −0 | −0 | −0 | — |
| EBIT | 12 | 1 | −1 | −9 |
| Net financials | — | — | — | 1 |
| Profit before tax | 11 | 1 | −1 | −9 |
| Tax | −2 | −0 | −0 | — |
| Net profit | 9 | 1 | −1 | −9 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 56 | 48 | 40 | 39 |
| Equity | 34 | 35 | 25 | 16 |
| Long-term debt | 0 | 0 | 0 | — |
| Short-term debt | 21 | 13 | 15 | 22 |
| Total debt | 21 | 13 | 15 | 22 |
EBITDA margin
-930000.0%
This company
15.8%
Market median
-5886176% vs market
20222025
Equity ratio
42.3%
This company
38.2%
Market median
+11% vs market
20222025
Return on equity
-53.4%
This company
18.4%
Market median
-390% vs market
20222025
Net profit margin
-870500.0%
This company
8.1%
Market median
-10747014% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
1.36×
This company
0.62×
Market median
-119% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LG Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ocampo medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Göran Ahlberg | Liquidator | 0 companies |
| Luisa Fernanda Ocampo Molano | Board of Directors | 0 companies |
| Liliana Maria Ocampo Molano | Deputy Board Member | 0 companies |